Picture of Annexin Pharmaceuticals AB (publ) logo

ANNX — Annexin Pharmaceuticals AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Annexin Pharmaceuticals In Collaboration For Covid-19 Study

May 18 (Reuters) - Annexin Pharmaceuticals AB (publ)
 ANNX.ST :
    * ANNEXIN PHARMACEUTICALS IN COLLABORATION FOR COVID-19
STUDY
    * PHYSICIANS IN NETHERLANDS PLAN TO START A COVID-19 STUDY
WITH
ANNEXIN PHARMACEUTICALS DRUG CANDIDATE ANXV AND HAVE TO THIS END
SUBMITTED AN APPLICATION TO LOCAL AUTHORITY
    * ANNEXIN PHARMACEUTICALS WILL PROVIDE ANXV AND HAS SECURED
FUNDING TO TAKE PART IN STUDY

Source text for Eikon:  ID:nWkrPZGvf 
Further company coverage:  ANNX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Annexin Pharmaceuticals AB (publ)

See all news